Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX Income Before Tax

Profit after all operating and non-operating items but before income tax.

Orthofix Medical Inc.NASDAQ: OFIX

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax remains negative

Q1 FY2026 income before tax was -$20.83M, compared with -$52.13M a year earlier. Trailing-twelve-month income before tax was -$59.51M.

Context

  • Income before tax amounted to 11.0% of revenue in FY2025, down 4.5 pp from a year earlier.
  • Income before tax grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly income before tax holds near -$20.83M or moves back toward the trailing-twelve-month quarterly average of -$14.88M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$20.83M-850.5% QoQ
Last fiscal yearDec 2025
-$90.81M+26.7% YoY
LTMMar 2026
-$59.51M+57.7% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+60.0%——
1 year+26.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(90.81M) USD
Year-over-year change
+26.7%

Income Before Tax vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's LTM Mar 2026 income before tax of -$59.51M is the 4th highest of the 11 companies compared; the peer median is -$75.39M.
  • Its year-over-year change of +57.7% is the 5th highest of 11, against a peer median of +28.5%.
  • Income before tax amounts to 7.2% of revenue for OFIX, versus a peer median of 73.5%.
OFIX Competitors Peer median
Income Before Tax for OFIX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DRIODarioHealth Corp.LTM Mar 2026$62.75M +240.6%—296.1%
ESPREsperion Therapeutics, Inc.LTM Mar 2026-$5.58M +96.4%—1.3%
SIBNSI-BONE, Inc.LTM Mar 2026-$16.7M +37.1%—8.1%
OFIXOrthofix Medical Inc.LTM Mar 2026-$59.51M +57.7%—7.2%
AVNSAvanos Medical, Inc.LTM Mar 2026-$68.3M +82.7%—9.5%
VREXVarex Imaging CorporationLTM Apr 2026-$75.1M -552.4%—8.8%
BFLYButterfly Network, Inc.LTM Mar 2026-$75.67M -16.9%—73.5%
LABStandard BioTools Inc.LTM Mar 2026-$87.83M +19.8%—101.8%
ABSIAbsci CorporationLTM Mar 2026-$118.35M -10.2%—6445.8%
PACBPacific Biosciences of California, Inc.LTM Mar 2026-$127.77M +80.6%—79.8%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026-$258.39M -75.2%——
Peer median (excluding OFIX) -$75.39M+28.5%—73.5%

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue464.48M460.71M746.64M799.49M822.31M
Cost of Revenue114.91M123.54M260.37M253.61M270.61M
Gross Profit349.57M337.17M486.27M545.89M551.71M
Gross Margin75.3%73.2%65.1%68.3%67.1%
Research & Development49.62M49.07M80.23M73.64M57.11M
Selling, General & Admin290.67M308.78M530.4M532.53M456.39M
Operating Expenses357.88M350.44M625.38M630.5M620.18M
Depreciation & Amortization33.1M32.08M60.56M60.06M50.97M
EBITDA21.44M15.66M(79.49M)(34.18M)(22.35M)
EBITDA Margin4.6%3.4%-10.6%-4.3%-2.7%
Operating Income(8.32M)(13.27M)(139.11M)(84.62M)(68.47M)
Operating Margin-1.8%-2.9%-18.6%-10.6%-8.3%
Interest Income00000
Interest Expense1.84M1.29M8.63M29.63M17.49M
Other Income / Expenses(5.18M)(4.44M)(9.57M)(39.26M)(22.34M)
Income Before Tax(13.5M)(17.71M)(148.68M)(123.88M)(90.81M)
Pre-Tax Margin-2.9%-3.8%-19.9%-15.5%-11.0%
Income Tax Expense24.88M2.04M2.72M2.12M1.38M
Net Income(38.38M)(19.75M)(151.4M)(126M)(92.19M)
Net Margin-8.3%-4.3%-20.3%-15.8%-11.2%
EPS (Basic)(1.95)(0.98)(4.12)(3.30)(2.28)
EPS (Diluted)(1.95)(0.98)(4.12)(3.30)(2.28)
Weighted Avg Shares19.69M20.1M36.73M38.13M39.88M
Weighted Avg Shares (Diluted)19.69M20.1M36.73M38.13M39.88M

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.